EIT Pathogena
EIT Pathogena is a cutting-edge genomic analysis platform for academics and public health professionals around the world to help fight infectious diseases.
Our History
Since its inception, GPAS Ltd has been funded by Larry Ellison, founder and CTO of Oracle Inc, with the objective of building a genomic pathogen analysis platform that supports clinical decisions and public health surveillance to improve global health.
Joining EIT Oxford
EIT Oxford is a major new interdisciplinary research and development facility that translates scientific research and discovery into end-to-end solutions to solve the world’s most enduring challenges.
Guided by our President, Professor Sir John Bell, alongside world leaders, scientists, and entrepreneurs, EIT works in four areas of scientific and technological innovation: health and medical science, food security and sustainable agriculture, climate change and clean energy, and government innovation in the era of artificial intelligence.
Specifically, our health & medical science area seeks to:
Improve the quality and lower the cost of healthcare worldwide.
Use generative artificial intelligence to accelerate innovation.
Use digital cloud infrastructure to equitably distribute lifesaving vaccines, therapeutics, and technologies globally.
It's the beginning of a new era, marked by cutting-edge research, innovation, and collaboration.
Our Vision
Transformational innovation within sample preparation and sequencing technologies will speed the movement of genomic testing from remote central labs to a ‘sequencing first’ approach from clinicians at routine points of care.
We are dedicated to pushing the boundaries of what's possible in pathogen analysis and global health improvement. We will save lives avoidably lost to infectious diseases through our simple ethos – authentic collaboration.
What's Important to Us
By working together, we can accelerate the development and equitable distribution of innovative solutions, ensuring that our vision becomes a reality in the shortest possible time.
These partnerships enable sharing knowledge, leveraging advanced technologies, and implementing best practices across different regions, ultimately enhancing our ability to respond to public health threats swiftly and efficiently.